{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:41:57Z","timestamp":1793263317585,"version":"4.5.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T00:00:00Z","timestamp":1748131200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T00:00:00Z","timestamp":1748131200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Artif Organs"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In glucose management using continuous insulin infusion, artificial pancreas systems prevent blood glucose fluctuations and severe hypoglycemia using insulin pumps and continuous glucose monitoring. Advances in both insulin pumps and continuous glucose monitoring have enabled the transition from sensor augmented pump therapy, where insulin delivery is manually adjusted, to hybrid closed-loop insulin pump therapy, which automatically adjusts basal insulin infusion. Furthermore, fully automated insulin delivery systems that adjust insulin based on variations due to meals and exercise are now possible. These systems have been primarily applied to patients with type 1 diabetes but are now expanding to all insulin-dependent patients. Wearable artificial pancreas systems measure glucose levels in subcutaneous tissue fluid, while bedside artificial pancreas systems measure glucose levels in venous blood, making them suitable for managing the highly variable blood glucose levels of perioperative and critically ill patients. Future developments are anticipated to integrate the benefits of both wearable and bedside systems.<\/jats:p>","DOI":"10.1007\/s10047-025-01510-1","type":"journal-article","created":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T13:07:44Z","timestamp":1748178464000},"page":"514-521","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Artificial pancreas: the past and the future"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2336-3416","authenticated-orcid":false,"given":"Hiroyuki","family":"Kitagawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Munekage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Hanazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,25]]},"reference":[{"key":"1510_CR1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s10047-011-0611-7","volume":"15","author":"K Mibu","year":"2012","unstructured":"Mibu K, Yatabe T, Hanazaki K. Blood glucose control using an artificial pancreas reduces the workload of ICU nurses. J Artif Organs. 2012;15:71\u20136.","journal-title":"J Artif Organs"},{"key":"1510_CR2","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.amjsurg.2013.07.048","volume":"207","author":"K Hanazaki","year":"2014","unstructured":"Hanazaki K, Kitagawa H, Yatabe T, et al. Perioperative intensive insulin therapy using an artificial endocrine pancreas with closed-loop glycemic control system: the effects of no hypoglycemia. Am J Surg. 2014;207:935\u201341.","journal-title":"Am J Surg"},{"key":"1510_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s10047-016-0904-y","volume":"19","author":"K Hanazaki","year":"2016","unstructured":"Hanazaki K, Munekage M, Kitagawa H, et al. Current topics in glycemic control by wearable artificial pancreas or bedside artificial pancreas with closed-loop system. J Artif Organs. 2016;19:209\u201318.","journal-title":"J Artif Organs"},{"key":"1510_CR4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1177\/1932296818795150","volume":"13","author":"L Heinemann","year":"2019","unstructured":"Heinemann L, Waldenmaier D, Kulzer B, Ziegler R, Ginsberg B, Freckmann G. Patch pumps: are they all the same? J Diabetes Sci Technol. 2019;13:34\u201340.","journal-title":"J Diabetes Sci Technol"},{"key":"1510_CR5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2337\/ds18-0094","volume":"32","author":"N Taleb","year":"2019","unstructured":"Taleb N, Tagougui S, Rabasa-Lhoret R. Single-hormone artificial pancreas use in diabetes: clinical efficacy and remaining challenges. Diabetes Spectr. 2019;32:205\u20138.","journal-title":"Diabetes Spectr"},{"key":"1510_CR6","doi-asserted-by":"publisher","first-page":"597","DOI":"10.2337\/dc19-1922","volume":"43","author":"A Haidar","year":"2020","unstructured":"Haidar A, Tsoukas MA, Bernier-Twardy S, Yale JF, Rutkowski J, Bossy A, et al. A Novel dual-hormone insulin-and-pramlintide artificial pancreas for type 1 diabetes: a randomized controlled crossover trial. Diabetes Care. 2020;43:597\u2013606.","journal-title":"Diabetes Care"},{"key":"1510_CR7","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.2337\/diacare.26.8.2405","volume":"26","author":"E Kulcu","year":"2003","unstructured":"Kulcu E, Tamada JA, Reach G, Potts RO, Lesho MJ. Physiological differences between interstitial glucose and blood glucose measured in human subjects. Diabetes Care. 2003;26:2405\u20139.","journal-title":"Diabetes Care"},{"key":"1510_CR8","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.2337\/dci24-0073","volume":"47","author":"JLV Shaw","year":"2024","unstructured":"Shaw JLV, Bannuru RR, Beach L, ElSayed NA, Freckmann G, F\u00fcz\u00e9ry AK, et al. Consensus considerations and good practice points for use of continuous glucose monitoring systems in hospital settings. Diabetes Care. 2024;47:2062\u201375.","journal-title":"Diabetes Care"},{"key":"1510_CR9","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2337\/dc23-1520","volume":"47","author":"S Seidu","year":"2024","unstructured":"Seidu S, Kunutsor SK, Ajjan RA, et al. Efficacy and safety of continuous glucose monitoring and intermittently scanned continuous glucose monitoring in patients with type 2 diabetes: a systematic review and meta-analysis of interventional evidence. Diabetes Care. 2024;47:169\u201379.","journal-title":"Diabetes Care"},{"key":"1510_CR10","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1111\/dme.14065","volume":"36","author":"IB Hirsch","year":"2019","unstructured":"Hirsch IB, Welsh JB, Calhoun P, et al. Associations between HbA1c and continuous glucose monitoring-derived glycemic variables. Diabetes Med. 2019;36:1637\u201342.","journal-title":"Diabetes Med"},{"key":"1510_CR11","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.2337\/dc18-1581","volume":"41","author":"RM Bergenstal","year":"2018","unstructured":"Bergenstal RM, Beck RW, Close KL, et al. Glucose management indicator (GMI): a new term for estimating A1C from continuous glucose monitoring. Diabetes Care. 2018;41:2275\u201380.","journal-title":"Diabetes Care"},{"key":"1510_CR12","doi-asserted-by":"publisher","first-page":"400","DOI":"10.2337\/dc18-1444","volume":"42","author":"RW Beck","year":"2019","unstructured":"Beck RW, Bergenstal RM, Riddlesworth TD, et al. Validation of time in range as an outcome measure for diabetes clinical trials. Diabetes Care. 2019;42:400\u20135.","journal-title":"Diabetes Care"},{"key":"1510_CR13","doi-asserted-by":"publisher","first-page":"549","DOI":"10.2337\/dc20-1862","volume":"44","author":"J Lu","year":"2021","unstructured":"Lu J, Wang C, Shen Y, et al. Time in range in relation to all-cause and cardiovascular mortality in patients with type 2 diabetes: a prospective cohort study. Diabetes Care. 2021;44:549\u201355.","journal-title":"Diabetes Care"},{"key":"1510_CR14","doi-asserted-by":"publisher","first-page":"790","DOI":"10.2337\/dc23-1581","volume":"47","author":"J Casta\u00f1eda","year":"2024","unstructured":"Casta\u00f1eda J, Arrieta A, van den Heuvel T, et al. Time in tight glucose range in type 1 diabetes: predictive factors and achievable targets in real-world users of the MiniMed 780G System. Diabetes Care. 2024;47:790\u20137.","journal-title":"Diabetes Care"},{"key":"1510_CR15","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/dci19-0028","volume":"42","author":"T Battelino","year":"2019","unstructured":"Battelino T, Danne T, Bergenstal RM, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019;42:1593\u2013603.","journal-title":"Diabetes Care"},{"key":"1510_CR16","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1177\/19322968221085273","volume":"17","author":"DC Klonoff","year":"2023","unstructured":"Klonoff DC, Wang J, Rodbard D, Kohn MA, Li C, Liepmann D, et al. A glycemia risk index (GRI) of hypoglycemia and hyperglycemia for continuous glucose monitoring validated by clinician ratings. J Diabetes Sci Technol. 2023;17:1226\u201342.","journal-title":"J Diabetes Sci Technol"},{"key":"1510_CR17","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1016\/S0140-6736(21)00789-3","volume":"397","author":"MM Visser","year":"2021","unstructured":"Visser MM, Charleer S, Fieuws S, et al. Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial. Lancet. 2021;397:2275\u201383.","journal-title":"Lancet"},{"key":"1510_CR18","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.2337\/dc17-1600","volume":"40","author":"T Danne","year":"2017","unstructured":"Danne T, Nimri R, Battelino T, et al. International consensus on use of continuous glucose monitoring. Diabetes Care. 2017;40:1631\u201340.","journal-title":"Diabetes Care"},{"key":"1510_CR19","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.2337\/dc21-0932","volume":"44","author":"J Garcia-Tirado","year":"2021","unstructured":"Garcia-Tirado J, Diaz JL, Esquivel-Zuniga R, et al. Advanced closed-loop control system improves postprandial glycemic control compared with a hybrid closed-loop system following unannounced meal. Diabetes Care. 2021;44:2379\u201387.","journal-title":"Diabetes Care"},{"key":"1510_CR20","doi-asserted-by":"publisher","first-page":"e839","DOI":"10.1016\/S2666-7568(22)00266-5","volume":"3","author":"S Trawley","year":"2022","unstructured":"Trawley S, Ward GM, Vogrin S, et al. Glucose profiles of older adults with type 1 diabetes using sensor-augmented pump therapy in Australia: pre-randomisation results from the ORACL study. Lancet Healthy Longev. 2022;3:e839\u201348.","journal-title":"Lancet Healthy Longev"},{"key":"1510_CR21","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.2337\/dc23-0635","volume":"46","author":"TSJ Crabtree","year":"2023","unstructured":"Crabtree TSJ, Griffin TP, Yap YW, et al. Hybrid closed-loop therapy in adults with type 1 diabetes and above-target HbA1c: A Real-world Observational Study. Diabetes Care. 2023;46:1831\u20138.","journal-title":"Diabetes Care"},{"key":"1510_CR22","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1056\/NEJMoa2210834","volume":"388","author":"RP Wadwa","year":"2023","unstructured":"Wadwa RP, Reed ZW, Buckingham BA, et al. PEDAP trial study group: trial of hybrid closed-loop control in young children with type 1 diabetes. N Engl J Med. 2023;388:991\u20131001.","journal-title":"N Engl J Med"},{"key":"1510_CR23","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41591-022-02144-z","volume":"29","author":"AB Daly","year":"2023","unstructured":"Daly AB, Boughton CK, Nwokolo M, et al. Fully automated closed-loop insulin delivery in adults with type 2 diabetes: an open-label, single-center, randomized crossover trial. Nat Med. 2023;29:203\u20138.","journal-title":"Nat Med"},{"key":"1510_CR24","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.2337\/dc23-0635","volume":"46","author":"TSJ Crabtree","year":"2023","unstructured":"Crabtree TSJ, Griffin TP, Yap YW, Narendran P, Gallen G, Furlong N, ABCD Closed-Loop Audit Contributors, et al. Hybrid closed-loop therapy in adults with type 1 diabetes and above-target HbA1c: A Real-world Observational Study. Diabetes Care. 2023;46:1831\u20138.","journal-title":"Diabetes Care"},{"key":"1510_CR25","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s00592-022-01886-z","volume":"59","author":"R Schiaffini","year":"2022","unstructured":"Schiaffini R, Deodati A, Nicoletti MC, Carducci C, Ciampalini P, Lorubbio A, et al. Comparison of two advanced hybrid closed loop in a pediatric population with type 1 diabetes: a real-life observational study. Acta Diabetol. 2022;59:959\u201364.","journal-title":"Acta Diabetol"},{"key":"1510_CR26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1089\/dia.2021.0203","volume":"24","author":"JD Silva","year":"2022","unstructured":"Silva JD, Lepore G, Battelino T, Arrieta A, Casta\u00f1eda J, Grossman B, et al. Real-world performance of the MiniMed\u2122 780G system: first report of outcomes from 4120 users. Diabetes Technol Ther. 2022;24:113\u20139.","journal-title":"Diabetes Technol Ther"},{"key":"1510_CR27","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0140-6736(16)32567-3","volume":"389","author":"FH El-Khatib","year":"2017","unstructured":"El-Khatib FH, Balliro C, Hillard MA, Magyar KL, Ekhlaspour L, Sinha M, et al. Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial. Lancet. 2017;389:369\u201380.","journal-title":"Lancet"},{"key":"1510_CR28","doi-asserted-by":"publisher","first-page":"836","DOI":"10.2337\/dc20-2106","volume":"44","author":"H Blauw","year":"2021","unstructured":"Blauw H, Onvlee AJ, Klaassen M, van Bon AC, DeVries JH. Fully closed loop glucose control with a bihormonal artificial pancreas in adults with type 1 diabetes: an outpatient, randomized. Crossover Trial Diabetes Care. 2021;44:836\u20138.","journal-title":"Crossover Trial Diabetes Care"},{"key":"1510_CR29","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1001\/jamasurg.2022.3702","volume":"157","author":"CL van Veldhuisen","year":"2022","unstructured":"van Veldhuisen CL, Latenstein AEJ, Blauw H, et al. Bihormonal artificial pancreas with closed-loop glucose control vs current diabetes care after total pancreatectomy: a randomized clinical trial. JAMA Surg. 2022;157:950\u20137.","journal-title":"JAMA Surg"},{"key":"1510_CR30","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1177\/193229681300700416","volume":"7","author":"P Herrero","year":"2013","unstructured":"Herrero P, Georgiou P, Oliver N, Reddy M, Johnston D, Toumazou C. A composite model of glucagon-glucose dynamics for in silico testing of bihormonal glucose controllers. J Diabetes Sci Technol. 2013;7:941\u201351.","journal-title":"J Diabetes Sci Technol"},{"key":"1510_CR31","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/ALN.0b013e3181948a80","volume":"110","author":"AK Lipshutz","year":"2009","unstructured":"Lipshutz AK, Gropper MA. Perioperative glycemic control: an evidence-based review. Anesthesiology. 2009;110:408\u201321.","journal-title":"Anesthesiology"},{"key":"1510_CR32","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1086\/501830","volume":"22","author":"R Latham","year":"2001","unstructured":"Latham R, Lancaster AD, Covington JF, et al. The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol. 2001;22:607\u201312.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1510_CR33","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1086\/502133","volume":"24","author":"SJ Wilson","year":"2003","unstructured":"Wilson SJ, Sexton DJ. Elevated preoperative fasting serum glucose levels increase the risk of postoperative mediastinitis in patients undergoing open heart surgery. Infect Control Hosp Epidemiol. 2003;24:776\u20138.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1510_CR34","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1001\/archsurg.141.4.375","volume":"141","author":"AS Dronge","year":"2006","unstructured":"Dronge AS, Perkal MF, Kancir S, et al. Long-term glycemic control and postoperative infectious complications. Arch Surg. 2006;141:375\u201380.","journal-title":"Arch Surg"},{"key":"1510_CR35","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.2337\/dc10-0304","volume":"33","author":"A Frisch","year":"2010","unstructured":"Frisch A, Chandra P, Smiley D, et al. Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery. Diabetes Care. 2010;33:1783\u20138.","journal-title":"Diabetes Care"},{"key":"1510_CR36","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/SLA.0b013e3182a501e3","volume":"258","author":"RP Kiran","year":"2013","unstructured":"Kiran RP, Turina M, Hammel J, Fazio V. The clinical significance of an elevated postoperative glucose value in nondiabetic patients after colorectal surgery: evidence for the need for tight glucose control? Ann Surg. 2013;258:599\u2013604.","journal-title":"Ann Surg"},{"key":"1510_CR37","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/SLA.0b013e31827b6bbc","volume":"257","author":"S Kwon","year":"2013","unstructured":"Kwon S, Thompson R, Dellinger P, et al. Importance of perioperative glycemic control in general surgery: a report from the surgical care and outcomes assessment program. Ann Surg. 2013;257:8\u201314.","journal-title":"Ann Surg"},{"key":"1510_CR38","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1042\/cs0790443","volume":"79","author":"LS Brandi","year":"1990","unstructured":"Brandi LS, Frediani M, Oleggini M, et al. Insulin resistance after surgery: normalization by insulin treatment. Clin Sci (Lond). 1990;79:443\u201350.","journal-title":"Clin Sci (Lond)"},{"key":"1510_CR39","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.clnesp.2020.11.023","volume":"41","author":"MA Roszali","year":"2021","unstructured":"Roszali MA, Zakaria AN, Mohd Tahir NA. Parenteral nutrition-associated hyperglycemia: prevalence, predictors and management. Clin Nutr ESPEN. 2021;41:275\u201380.","journal-title":"Clin Nutr ESPEN"},{"key":"1510_CR40","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1001\/jamasurg.2017.0904","volume":"152","author":"SI Berr\u00edos-Torres","year":"2017","unstructured":"Berr\u00edos-Torres SI, Umscheid CA, Bratzler DW, et al. Centers for disease control and prevention guideline for the prevention of surgical site infection, 2017. JAMA Surg. 2017;152:784\u201391.","journal-title":"JAMA Surg"},{"key":"1510_CR41","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jamcollsurg.2016.10.029","volume":"224","author":"KA Ban","year":"2016","unstructured":"Ban KA, Minei JP, Laronga C, et al. American College of Surgeons and Surgical Infection Society: surgical site infection guidelines, 2016 update. J Am Coll Surg. 2016;224:59\u201374.","journal-title":"J Am Coll Surg"},{"key":"1510_CR42","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2337\/dc24-S016","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2024","unstructured":"American Diabetes Association Professional Practice Committee. 16 Diabetes care in the hospital: standards of care in diabetes-2024. Diabetes Care. 2024;47:295\u2013306.","journal-title":"Diabetes Care"},{"key":"1510_CR43","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1056\/NEJMoa011300","volume":"345","author":"G van den Berghe","year":"2001","unstructured":"van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359\u201367.","journal-title":"N Engl J Med"},{"key":"1510_CR44","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1056\/NEJMoa052521","volume":"354","author":"G Van den Berghe","year":"2006","unstructured":"Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449\u201361.","journal-title":"N Engl J Med"},{"key":"1510_CR45","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1056\/NEJMoa070716","volume":"358","author":"FM Brunkhorst","year":"2008","unstructured":"Brunkhorst FM, Engel C, Bloos F, German Competence Network Sepsis (SepNet) group, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125\u201339.","journal-title":"N Engl J Med"},{"key":"1510_CR46","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1007\/s00134-009-1585-2","volume":"35","author":"JC Preiser","year":"2009","unstructured":"Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: The Glucontrol Study. Intensive Care Med. 2009;35:1738\u201348.","journal-title":"Intensive Care Med"},{"key":"1510_CR47","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1056\/NEJMoa0810625","volume":"360","author":"S Finfer","year":"2009","unstructured":"Finfer S, Chittock DR, Su SY, NICE-SUGAR Study Investigators, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283\u201397.","journal-title":"N Engl J Med"},{"key":"1510_CR48","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.2337\/db06-0855","volume":"55","author":"G Van den Berghe","year":"2006","unstructured":"Van den Berghe G, Wilmer A, Milants I, et al. Intensive insulin therapy in mixed medical\/surgical intensive care units: benefit versus harm. Diabetes. 2006;55:3151\u20139.","journal-title":"Diabetes"},{"key":"1510_CR49","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1097\/CCM.0b013e3182653269","volume":"40","author":"J Jacobi","year":"2012","unstructured":"Jacobi J, Bircher N, Krinsley J, et al. Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med. 2012;40:3251\u201376.","journal-title":"Crit Care Med"},{"key":"1510_CR50","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.athoracsur.2008.11.011","volume":"87","author":"HL Lazar","year":"2009","unstructured":"Lazar HL, McDonnell M, Chipkin SR, et al. The Society of Thoracic Surgeons practice guideline series: blood glucose management during adult cardiac surgery. Ann Thorac Surg. 2009;87:663\u20139.","journal-title":"Ann Thorac Surg"},{"key":"1510_CR51","first-page":"4757","volume":"14","author":"Y Yao","year":"2022","unstructured":"Yao Y, Zhao YH, Zheng WH, Huang HB. Subcutaneous continuous glucose monitoring in critically ill patients during insulin therapy: a meta-analysis. Am J Transl Res. 2022;14:4757\u201367.","journal-title":"Am J Transl Res"},{"key":"1510_CR52","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s13054-015-0908-7","volume":"19","author":"JS Krinsley","year":"2015","unstructured":"Krinsley JS, Preiser JC. Time in blood glucose range 70 to 140 mg\/dl >80% is strongly associated with increased survival in non-diabetic critically ill adults. Crit Care. 2015;19:179.","journal-title":"Crit Care"},{"key":"1510_CR53","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1056\/NEJMoa2304855","volume":"389","author":"J Gunst","year":"2023","unstructured":"Gunst J, Debaveye Y, G\u00fciza F, Dubois J, De Bruyn A, Dauwe D, TGC-Fast Collaborators, et al. Tight blood-glucose control without early parenteral nutrition in the ICU. N Engl J Med. 2023;389:1180\u201390.","journal-title":"N Engl J Med"},{"key":"1510_CR54","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S2213-8587(24)00058-5","volume":"12","author":"C von Loeffelholz","year":"2024","unstructured":"von Loeffelholz C, Birkenfeld AL. Tight versus liberal blood-glucose control in the intensive care unit: special considerations for patients with diabetes. Lancet Diabetes Endocrinol. 2024;12:277\u201384.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1510_CR55","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1097\/CCM.0000000000004599","volume":"48","author":"JS Krinsley","year":"2020","unstructured":"Krinsley JS, Rule P, Pappy L, Ahmed A, Huley-Rodrigues C, Prevedello D, Preiser JC. The interaction of acute and chronic glycemia on the relationship of hyperglycemia, hypoglycemia, and glucose variability to mortality in the critically ill. Crit Care Med. 2020;48:1744\u201351.","journal-title":"Crit Care Med"},{"key":"1510_CR56","doi-asserted-by":"publisher","first-page":"e233","DOI":"10.1097\/CCM.0000000000004213","volume":"48","author":"TN Kwan","year":"2020","unstructured":"Kwan TN, Zwakman-Hessels L, Marhoon N, Robbins R, M\u00e5rtensson J, Ekinci E, et al. Relative hypoglycemia in diabetic patients with critical illness. Crit Care Med. 2020;48:e233\u201340.","journal-title":"Crit Care Med"},{"key":"1510_CR57","doi-asserted-by":"publisher","first-page":"e664","DOI":"10.1097\/CCM.0000000000005490","volume":"50","author":"JS Krinsley","year":"2022","unstructured":"Krinsley JS, Rule PR, Roberts GW, Brownlee M, Preiser JC, Chaudry S, et al. Relative hypoglycemia and lower hemoglobin A1c-adjusted time in band are strongly associated with increased mortality in critically ill patients. Crit Care Med. 2022;50:e664\u201373.","journal-title":"Crit Care Med"},{"key":"1510_CR58","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1177\/1932296818822496","volume":"13","author":"RW Beck","year":"2019","unstructured":"Beck RW, Bergenstal RM, Cheng P, et al. The relationships between time in range, hyperglycemia metrics, and HbA1c. J Diabetes Sci Technol. 2019;13:614\u201326.","journal-title":"J Diabetes Sci Technol"},{"key":"1510_CR59","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1177\/19322968221124114","volume":"18","author":"G Roberts","year":"2024","unstructured":"Roberts G, Krinsley JS, Preiser JC, Quinn S, Rule PR, Brownlee M, et al. The glycemic ratio is strongly and independently associated with mortality in the critically ill. J Diabetes Sci Technol. 2024;18:335\u201344.","journal-title":"J Diabetes Sci Technol"},{"key":"1510_CR60","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1097\/CCM.0000000000006313","volume":"52","author":"T Okazaki","year":"2024","unstructured":"Okazaki T, Nabeshima T, Santanda T, Hoshina Y, Kondo Y, Yaegashi Y, et al. Association of relative dysglycemia with hospital mortality in critically ill patients: a retrospective study. Crit Care Med. 2024;52:1356\u201366.","journal-title":"Crit Care Med"},{"key":"1510_CR61","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2337\/dc22-1445","volume":"46","author":"MW Schwartz","year":"2023","unstructured":"Schwartz MW, Krinsley JS, Faber CL, Hirsch IB, Brownlee M. Brain glucose sensing and the problem of relative hypoglycemia. Diabetes Care. 2023;46:237\u201344.","journal-title":"Diabetes Care"},{"key":"1510_CR62","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1111\/aor.14008","volume":"45","author":"K Hanazaki","year":"2021","unstructured":"Hanazaki K, Tanioka N, Munekage M, et al. Closed-loop artificial endocrine pancreas from Japan. Artif Organs. 2021;45:958\u201367.","journal-title":"Artif Organs"},{"key":"1510_CR63","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1525-1594.2004.29008.x","volume":"29","author":"T Kono","year":"2005","unstructured":"Kono T, Hanazaki K, Yazawa K, et al. Pancreatic polypeptide administration reduces insulin requirements of artificial pancreas in pancreatectomized dogs. Artif Organs. 2005;29:83\u20137.","journal-title":"Artif Organs"},{"key":"1510_CR64","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1213\/01.ane.0000296461.26492.3c","volume":"106","author":"K Yamashita","year":"2008","unstructured":"Yamashita K, Okabayashi T, Yokoyama T, et al. The accuracy of a continuous blood glucose monitors during surgery. Anesth Analg. 2008;106:160\u20133.","journal-title":"Anesth Analg"},{"key":"1510_CR65","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.21873\/anticanres.11117","volume":"36","author":"H Kitagawa","year":"2016","unstructured":"Kitagawa H, Yatabe T, Namikawa T, et al. Postoperative closed-loop glycemic control using an artificial pancreas in patients after esophagectomy. Anticancer Res. 2016;36:4063\u20137.","journal-title":"Anticancer Res"},{"key":"1510_CR66","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12893-024-02365-8","volume":"24","author":"R Miyauchi","year":"2024","unstructured":"Miyauchi R, Miki Y, Kasashima H, Fukuoka T, Yoshii M, Tamura T, et al. Effects of an artificial pancreas on postoperative inflammation in patients with esophageal cancer. BMC Surg. 2024;24:77.","journal-title":"BMC Surg"},{"key":"1510_CR67","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s10047-015-0818-0","volume":"18","author":"K Mibu","year":"2015","unstructured":"Mibu K, Yatabe T, Yamasaki F, et al. Questionnaire survey on the use of a novel artificial pancreas by intensive care unit nurses. J Artif Organs. 2015;18:162\u20135.","journal-title":"J Artif Organs"},{"key":"1510_CR68","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s10047-023-01423-x","volume":"27","author":"H Kitagawa","year":"2024","unstructured":"Kitagawa H, Yokota K, Namikawa T, et al. A case of perioperative artificial pancreas therapy for a patient with esophageal cancer with type 1 diabetes. J Artif Organs. 2024;27:311\u20135.","journal-title":"J Artif Organs"},{"key":"1510_CR69","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/ags3.12374","volume":"4","author":"T Yoshimoto","year":"2020","unstructured":"Yoshimoto T, Ikemoto T, Morine Y, et al. Impact of using a perioperative artificial endocrine pancreas in pancreatic resection. Ann Gastroenterol Surg. 2020;4:591\u20136.","journal-title":"Ann Gastroenterol Surg"},{"key":"1510_CR70","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11748-020-01415-1","volume":"69","author":"K Aizawa","year":"2021","unstructured":"Aizawa K, Muraoka A, Kurumisawa S, et al. Artificial endocrine pancreas with a closed-loop system effectively suppresses the accelerated hyperglycemic status after reperfusion during aortic surgery. Gen Thorac Cardiovasc Surg. 2021;69:14\u20138.","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"1510_CR71","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.amjsurg.2008.11.046","volume":"199","author":"H Maeda","year":"2010","unstructured":"Maeda H, Okabayashi T, Nishimori I, et al. Hyperglycemia during hepatic resection: continuous monitoring of blood glucose concentration. Am J Surg. 2010;199:8\u201313.","journal-title":"Am J Surg"},{"key":"1510_CR72","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10047-020-01223-7","volume":"24","author":"U Shin","year":"2021","unstructured":"Shin U, Naoko H, Michinori T, Yuya K, Yuka S, Yuki N, et al. Utility of bedside artificial pancreas for postoperative glycemic control in cardiac surgery. J Artif Organs. 2021;24:225\u201333.","journal-title":"J Artif Organs"},{"key":"1510_CR73","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s10047-015-0877-2","volume":"19","author":"M Munekage","year":"2016","unstructured":"Munekage M, Yatabe T, Sakaguchi M, et al. Comparison of subcutaneous and intravenous continuous glucose monitoring accuracy in an operating room and an intensive care unit. J Artif Organs. 2016;19:159\u201366.","journal-title":"J Artif Organs"},{"key":"1510_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.diabet.2018.04.003","volume":"45","author":"A Quintal","year":"2019","unstructured":"Quintal A, Messier V, Rabasa-Lhoret R, Racine E. A critical review and analysis of ethical issues associated with the artificial pancreas. Diabetes Metab. 2019;45:1\u201310.","journal-title":"Diabetes Metab"},{"key":"1510_CR75","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1111\/aor.14821","volume":"48","author":"K Mibu","year":"2024","unstructured":"Mibu K, Kitagawa H, Namikawa T, et al. Usefulness of an interprofessional work manual for perioperative glucose control of an artificial pancreas. Artif Organs. 2024;48:1308\u201312.","journal-title":"Artif Organs"},{"key":"1510_CR76","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1177\/1932296818812062","volume":"13","author":"G Freckmann","year":"2019","unstructured":"Freckmann G, Pleus S, Grady M, et al. Measures of accuracy for continuous glucose monitoring and blood glucose monitoring devices. J Diabetes Sci Technol. 2019;13:575\u201383.","journal-title":"J Diabetes Sci Technol"},{"key":"1510_CR77","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.201807369","volume":"29","author":"S Chen","year":"2019","unstructured":"Chen S, Matsumoto H, Moro-oka Y, et al. Microneedle-array patch fabricated with enzyme-free polymeric components capable of a weekly on-demand insulin delivery. Adv Func Mater. 2019;29: e1807369.","journal-title":"Adv Func Mater"},{"key":"1510_CR78","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s42003-020-1026-x","volume":"3","author":"A Matsumoto","year":"2020","unstructured":"Matsumoto A, Kuwata H, Kimura S, et al. Hollow fiber-combined glucose-responsive gel technology as an in vivo electronics-free insulin delivery system. Commun Biol. 2020;3:313.","journal-title":"Commun Biol"},{"key":"1510_CR79","doi-asserted-by":"publisher","first-page":"956","DOI":"10.2337\/dc23-1663","volume":"47","author":"B Voglov\u00e1 Hagerf","year":"2024","unstructured":"Voglov\u00e1 Hagerf B, Protus M, Nemetova L, et al. Accuracy and Feasibility of Real-time Continuous Glucose Monitoring in Critically Ill Patients After Abdominal Surgery and Solid Organ Transplantation. Diabetes Care. 2024;47:956\u201363.","journal-title":"Diabetes Care"}],"container-title":["Journal of Artificial Organs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10047-025-01510-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10047-025-01510-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10047-025-01510-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T06:04:12Z","timestamp":1761199452000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10047-025-01510-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,25]]},"references-count":79,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1510"],"URL":"https:\/\/doi.org\/10.1007\/s10047-025-01510-1","relation":{},"ISSN":["1434-7229","1619-0904"],"issn-type":[{"value":"1434-7229","type":"print"},{"value":"1619-0904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,25]]},"assertion":[{"value":"25 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare, did not receive support from any organization for the submitted work that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}